WHO approves Siam Bioscience’s AstraZeneca vaccine for emergency use

23 Sept 05:33 Key points summarised by AI

The World Health Organization (WHO) officially approved Siam Bioscience, a Thai company, as a qualified production site for the AstraZeneca COVID-19 vaccine.
Siam Bioscience has been added to the WHO's Emergency Use Listing (EUL), allowing it to manufacture both the drug substance and drug product.
This recommendation follows a thorough review by the WHO and a positive opinion from the Australia Therapeutic Goods Administration (TGA).
Siam Bioscience, established to support Thai public health, had previously partnered with AstraZeneca to supply COVID-19 vaccines across Southeast Asia, with millions of doses already delivered to Thailand's Ministry of Public Health.

Six injured after car smashes into On Nut shopping mall

Yesterday 22:44 Key points summarised by AI

A 67-year-old woman drove her car through the glass frontage of a Bangkok shopping mall, injuring six people, including a six-year-old girl.
The driver claimed she accidentally pressed the accelerator instead of the brake after being startled, causing the vehicle to surge forward.
She apologized to the victims, promising insurance coverage and additional financial aid, while police continue to gather statements before filing charges.